Literature DB >> 9007593

Clinical development of a new inactivated hepatitis A vaccine.

E Vidor1, B Fritzell, S Plotkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9007593     DOI： 10.1007/bf01713047

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  141 in total

1.  Vaccination against hepatitis A: control 3 years after the first vaccination.

Authors:  R Berger; M Just
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

Review 2.  Prospects for a hepatitis A virus vaccine.

Authors:  B Flehmig; U Heinricy; M Pfisterer
Journal:  Prog Med Virol       Date:  1990

3.  Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions.

Authors:  M S Green; C Block; P E Slater
Journal:  Rev Infect Dis       Date:  1989 May-Jun

4.  Hepatitis A and health care personnel.

Authors:  J Germanaud
Journal:  Arch Intern Med       Date:  1994-04-11

5.  Radioimmunoassay for detection of antibody to hepatitis A virus. Results of clinical evaluation.

Authors:  S E Safford; S B Needleman; R H Decker
Journal:  Am J Clin Pathol       Date:  1980-07       Impact factor: 2.493

Review 6.  Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.

Authors:  B J Kendall; W G Cooksley
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

7.  Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.

Authors:  Y Lerman; T Shohat; S Ashkenazi; R Almog; S L Heering; J Shemer
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

8.  Anti-hepatitis A in the general population and in hepatitis A vaccinees using saliva and serum as diagnostic media.

Authors:  W M Hurni; D Laufer; W J Miller; J Ryan; B Watson
Journal:  Ann N Y Acad Sci       Date:  1993-09-20       Impact factor: 5.691

9.  Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

Authors:  M S Green; D Cohen; Y Lerman; M Sjogren; L N Binn; S Zur; R Slepon; G Robin; C Hoke; W Bancroft
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

10.  Hepatitis A seroprevalence in homosexual and heterosexual men.

Authors:  R Nandwani; S Caswell; F Boag; A G Lawrence; J C Coleman
Journal:  Genitourin Med       Date:  1994-10
View more
  6 in total

Review 1.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 2.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 3.  Aventis Pasteur vaccines containing inactivated hepatitis A virus: a compilation of immunogenicity data.

Authors:  E Vidor; R Dumas; V Porteret; F Bailleux; K Veitch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-06       Impact factor: 3.267

Review 4.  Biosensing strategies for the electrochemical detection of viruses and viral diseases - A review.

Authors:  Laís Canniatti Brazaca; Pãmyla Layene Dos Santos; Paulo Roberto de Oliveira; Diego Pessoa Rocha; Jéssica Santos Stefano; Cristiane Kalinke; Rodrigo Alejandro Abarza Muñoz; Juliano Alves Bonacin; Bruno Campos Janegitz; Emanuel Carrilho
Journal:  Anal Chim Acta       Date:  2021-03-12       Impact factor: 6.911

5.  Hepatitis A vaccination.

Authors:  Li Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-07-10       Impact factor: 3.452

Review 6.  Live attenuated hepatitis A vaccines developed in China.

Authors:  Zhi-Yi Xu; Xuan-Yi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.